Raptor Pharmaceutical Corp is a development-stage biotechnology Company which is dedicated to speeding the delivery of new treatment options to patients by working to improve existing therapeutics.


Updates from The Motley Fool

Latest updates on Raptor Pharmaceutical from Fool.com.


Stock Performance

RPTP vs. S&P 500 | 2 Year Performance
View Interactive RPTP Charts
Sponsored by

Key Data Points

Primary metrics and data points about Raptor Pharmaceutical.
Current Price: $7.27
Prev Close: $7.02
Open: $7.20
Bid: $5.12
Ask: $7.80
Day's Range: $7.02 - $7.30
52wk Range: $2.94 - $13.30
Volume: 842,727
Avg Vol 956,460
Market Cap: $618.69M
P/E (ttm): -8.16
EPS (ttm): -$0.86
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Raptor Pharmaceutical.
CAPS Rating 3 out of 5
 
46 Outperform
6 Underperform
CAPS All Stars
 
14 Outperform
3 Underperform

How do you think Raptor Pharmaceutical will perform against the market?



You pick for Raptor Pharmaceutical is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Julie Anne Smith, CEO

100% Approve

Based on 2 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Raptor Pharmaceutical.

Raptor Pharmaceutical Corp is a development-stage biotechnology Company which is dedicated to speeding the delivery of new treatment options to patients by working to improve existing therapeutics.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers